Transforming Autologous Fat Processing in Aesthetics and Beyond
Ep. 187 - Ahmed Zobi of Syntr
27 minute view/listen
May 2025
Available everywhere you podcast
Fat grafting is evolving—faster, cleaner, and more effective than ever before. Could a new fat-processing device reshape the future of regenerative beauty?
In this episode, Dr. Grant Stevens interviews Ahmed Zobi, CEO of Syntr Health Technologies, about a revolutionary advancement in autologous fat processing. Born from a university research project and fueled by personal motivation, Syntr’s rotor-based microfluidic system is the first FDA-cleared device of its kind to be used in a human clinical trial for facial fat grafting.
Ahmed explains how this cutting-edge, closed-system platform delivers highly viable fat cells for safer, cleaner, and more consistent outcomes—ideal for mid-face augmentation, breast reconstruction, and even orthopedic support. They dive into Syntr’s journey from NIH grants to commercialization, how the device is enabling next-generation PRP and exosome research, and why automation and reproducibility are critical for the future of regenerative medicine.
Whether you're a clinician, innovator, or investor, tune in to the latest episode of The Technology of Beauty for insights into the evolving landscape of biotechnological aesthetics.
Subscribe to
The Technology of Beauty
Produced and co-founded by Influx, The Technology of Beauty is the podcast of renowned plastic surgeon Dr. Grant Stevens. Tune in to hear interviews with the innovators and entrepreneurs who are shaping the future of aesthetics from the industry side.
